New strategies to counteract the establishment of a GBM immunosuppressive TME are aimed at repolarizing M2 to the M1 phenotype and reducing the recruitment of tumor-promoting macrophages by targeting chemoattractant molecules such as OPN. This evidence concerns the gene SPP1 and neoplasm.